North America Carbohydrase Market is expected to reach USD 2.31 billion by 2026 from USD 1.71 billion in 2021, growing at a CAGR of 6.19%. The Carbohydrase market is forecasted to show great potential over the mentioned period.
Carbohydrase is a kind of enzyme, with a large family of cellulase, amylase etc. Carbohydrase is an important raw material in various application in different industries like, food, beverages, animal feed, pharmaceuticals, leather, textile, and others. One of the major purpose of carbohydrase in these industries is to reduce the greenhouse gas emission and avoid wastage of other raw materials.
The pharmaceutical industry has shown a significant growth lately, which has been a key factor in the favour of carbohydrase market. Other important factors, driving the market growth include emerging applications of carbohydrase, advancements in technology in enzyme engineering as well as increasing demand in Asia-Pacific. On the other hand, the market is facing some restraints as well. These include high costs of production, and unfavourable pH and temperature in alpha-amylase activity. These factors are responsible for holding back the market from reaching its full potential.
The North America Carbohydrase market is segmented by source, type and application. On the basis of segmentation by source, the segments are animals, plants, microorganism, etc. The market segmentation based on type is done into amylase and cellulase. Based on segmentation by application the market is categorized into animal feed, food & beverages, pharmaceuticals and other applications as well.
Geographically the North America Carbohydrase Market is segmented into US, Canada and Rest of North America.
Key Players in the Market:
Major Key Players in the North America Carbohydrase Market are
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Source
5.1.1 Introduction
5.1.2 Plants
5.1.3 Animals
5.1.4 Microorganisms
5.1.5 Y-o-Y Growth Analysis, By Source
5.1.6 Market Attractiveness Analysis, By Source
5.1.7 Market Share Analysis, By Source
5.2 Type
5.2.1 Introduction
5.2.2 Amylases
5.2.3 Cellulases
5.2.4 Others
5.2.5 Y-o-Y Growth Analysis, By Type
5.2.6 Market Attractiveness Analysis, By Type
5.2.7 Market Share Analysis, By Type
5.3 Application
5.3.1 Introduction
5.3.2 Animal Feed
5.3.3 Pharmaceuticals
5.3.4 Food & Beverages
5.3.5 Other Applications
5.3.6 Y-o-Y Growth Analysis, By Application
5.3.7 Market Attractiveness Analysis, By Application
5.3.8 Market Share Analysis, By Application
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Source
6.1.3.3 By Type
6.1.3.4 By Application
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Source
6.1.4.3 By Type
6.1.4.4 By Application
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Source
6.1.5.3 By Type
6.1.5.4 By Application
6.2 United States
6.3 Canada
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Amano Enzyme Inc.
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Dyadic International Inc.
8.3 AB Enzymes GMBH
8.4 Novozymes
8.5 Advanced Enzymes
8.6 Royal DSM
8.7 CHR. Hansen Holding A/S
8.8 Verenium
8.9 Speciality Enzymes
8.10 E.I. Dupont De Numours & Co.
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Apr 2021
